Journal
JOURNAL OF HEADACHE AND PAIN
Volume 22, Issue 1, Pages -Publisher
BMC
DOI: 10.1186/s10194-021-01266-y
Keywords
Genetic variants; Neurexin; Synaptic vesicles; Gene-gene interaction; Neurotransmitter
Categories
Funding
- Sociedade Portuguesa de Cefaleias (SPC)
- Fundacao para a Ciencia e Tecnologia (FCT) [PTDC/MEC-NEU/29468/2017]
- European Commission
- Tecnifar fellowships
- European Regional Development Fund under the project 'Analisis y correlacion entre la epigenetica y la actividad cerebral para evaluar el riesgo de migrana cronica y episodica en mujeres' (Cooperation Programme Interreg V-A Spain-Portugal [POCTEP 2014-2020]
- European Regional Development Fund under the project 'Analisis y correlacion entre la epigenetica y la actividad cerebral para evaluar el riesgo de migrana cronica y episodica en mujeres' (Ministerio de Ciencia, Innovacion y Universidades)
Ask authors/readers for more resources
The study revealed significant gene-gene interactions between NRXN2, GABRE, and CASK in the female group, potentially aiding in a better understanding of migraine etiology. This highlights the synergistic effect between these genes and their relation to migraine susceptibility, offering insight for new therapeutic approaches in the future.
Background Migraine is a multifactorial disorder that is more frequent (two to four times) in women than in men. In recent years, our research group has focused on the role of neurotransmitter release and its regulation. Neurexin (NRXN2) is one of the components of the synaptic vesicle machinery, responsible for connecting intracellular fusion proteins and synaptic vesicles. Our aim was to continue exploring the role and interaction of proteins involved in the control and promotion of neurotransmission in migraine susceptibility. Methods A case-control study was performed comprising 183 migraineurs (148 females and 35 males) and 265 migraine-free controls (202 females and 63 males). Tagging single nucleotide polymorphisms of NRXN2 were genotyped to assess the association between NRXN2 and migraine susceptibility. The chi(2) test was used to compare allele frequencies in cases and controls and odds ratios were estimated with 95% confidence intervals. Haplotype frequencies were compared between groups. Gene-gene interactions were analysed using the Multifactor Dimensionality Reduction v2.0. Results We found a statistically significant interaction model (p = 0.009) in the female group between the genotypes CG of rs477138 (NRXN2) and CT of rs1158605 (GABRE). This interaction was validated by logistic regression, showing a significant risk effect [OR = 4.78 (95%CI: 1.76-12.97)] after a Bonferroni correction. Our data also supports a statistically significant interaction model (p = 0.011) in the female group between the GG of rs477138 in NRXN2 and, the rs2244325's GG genotype and rs2998250's CC genotype of CASK. This interaction was also validated by logistic regression, with a protective effect [OR = 0.08 (95%CI: 0.01-0.75)]. A weak interaction model was found between NRXN2-SYT1. We have not found any statistically significant allelic or haplotypic associations between NRXN2 and migraine susceptibility. Conclusions This study unravels, for the first time, the gene-gene interactions between NRXN2, GABRE - a GABA(A)-receptor - and CASK, importantly it shows the synergetic effect between those genes and its relation with migraine susceptibility. These gene interactions, which may be a part of a larger network, can potentially help us in better understanding migraine aetiology and in development of new therapeutic approaches.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available